Skip to content

Effect of pentoxifylline on motility & viability of spermatozoa from infertile asthenozoospermic males

Effect of pentoxifylline on motility & viability of spermatozoa from infertile asthenozoospermic males

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110175942N1
Enrollment
26
Registered
2015-06-13
Start date
2015-06-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility. Male infertility

Interventions

Intervention 1: In the intervention group: immediately to the sperm samples of pentoxifylline in the amount of 3.5 mmol (one mg per ml ) will be added. Intervention 2: In control group: samples are ex
Treatment - Drugs
In the intervention group: immediately to the sperm samples of pentoxifylline in the amount of 3.5 mmol (one mg per ml ) will be added.
In control group: samples are examined in normal conditions

Sponsors

Vice chancellor for Research,Tabriz University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Inclusion criteria:motility of sperm <=50% or rapid progressive <25% ; sperm count<20million per milliliter exclusion criteria : Use of pentoxifylline on last 9 hour

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Motility of sperm. Timepoint: After 45 min,24,36,48 hour. Method of measurement: Sperm Test.

Secondary

MeasureTime frame
Survival rates of sperm. Timepoint: After45 min,24,36,48 hour. Method of measurement: Sperm Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Aliye Ghasemzadeh

Alzahra hospital

alghasemzadeh@yahoo.co.uk; lahroudin@gmail.com+98 41 3557 1113

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026